🇺🇸 FDA
Patent

US 7879874

Quinuclidine derivatives and medicinal compositions containing the same

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7879874 (Quinuclidine derivatives and medicinal compositions containing the same) held by Almirall, S.A. expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P13/00